Clinical Trial Update: Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a treatment to improve insulin secretion in new-onset diabetes after renal transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-transplant Diabetes Mellitus

Snippet

Sponsor: Medical University of Vienna | Conditions: New Onset Diabetes Mellitus After Renal Transplantation | Phase 2 | Status: TERMINATED